Form 4: Astrana Health CEO Brandon Sim Reports Changes in Beneficial Ownership

Sentiment:

Form 4 Filing


Astrana Health's CEO, Brandon Sim, filed a Form 4 detailing the grant of restricted stock units and adjustments to his beneficial ownership, including holdings in family trusts.

Summary

  • Brandon Sim, CEO and President of Astrana Health, Inc., reported changes in his beneficial ownership of the company's common stock.
  • The report includes the grant of 86,305 restricted stock units (RSUs) on April 2, 2024, which vest in semi-annual installments starting October 2, 2024, contingent upon continued employment.
  • Sim's direct holdings include 988,925 shares, encompassing 668,584 unvested restricted stock shares vesting at various dates and upon achieving performance goals.
  • He also indirectly owns shares through the Sim Family Irrevocable Trust 2021 (258,824 shares) and the Brandon Sim 2020 Irrevocable Trust (392,816 shares), disclaiming beneficial ownership except for his pecuniary interest.
  • The company changed its name from Apollo Medical Holdings, Inc. to Astrana Health, Inc. on February 26, 2024.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing. The sentiment is neutral as it primarily reports changes in ownership rather than conveying positive or negative news about the company's performance.

Positives

  • The grant of restricted stock units to the CEO aligns his interests with the long-term performance of the company.
  • The vesting schedules for the restricted stock units and shares incentivize continued employment and achievement of performance goals.

Future Outlook

The document outlines the vesting schedule for restricted stock units and shares, indicating future equity compensation for the CEO contingent on continued employment and, in some cases, achievement of performance goals.

Management Comments

  • The Reporting Person disclaims beneficial ownership of securities held by the Sim Family Irrevocable Trust 2021 and the Brandon Sim 2020 Irrevocable Trust except to the extent of his pecuniary interest therein.

Industry Context

Form 4 filings are standard practice for company insiders to report changes in their ownership of company securities, providing transparency to investors.

Comparison to Industry Standards

  • Equity compensation through restricted stock units is a common practice among publicly traded companies to align executive interests with shareholder value.
  • Vesting schedules are typically structured to incentivize long-term performance and retention, which is consistent with industry norms.
  • Disclosure of indirect ownership through trusts is also a standard requirement to ensure transparency in beneficial ownership.

Stakeholder Impact

  • Shareholders are informed about changes in the CEO's ownership stake in the company.
  • Employees may be indirectly affected by the performance-based vesting of some restricted stock shares, as it aligns executive incentives with company goals.

Key Dates

DateDescription
2024-02-26Astrana Health, Inc. changed its legal name from Apollo Medical Holdings, Inc.
2024-04-02Date of transaction: Grant of 86,305 restricted stock units.
2024-04-03Date of signature for the Form 4 filing.
2024-06-27Vesting date for some restricted stock shares.
2024-09-30Beginning of semi-annual vesting installments for some restricted stock shares.
2024-10-02Beginning of semi-annual vesting installments for the granted restricted stock units.
2024-11-02Vesting date for some restricted stock shares.
2025-06-27Vesting date for some restricted stock shares.
2026-06-27Vesting date for some restricted stock shares.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.